Banner Alzheimer's Institute at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Banner Alzheimer's Institute takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on prevention research in people at high risk, from immunotherapy concepts to sharing genetic and biomarker results. Its work covers a planned BCG trial in preclinical Alzheimer's disease and psychosocial outcomes in the eSMARTER trial.

OrganizationCTAD 2026 Attendance
bannerhealth.com
Universities & institutes
Banner Health research and care institute that leads the Alzheimer's Prevention Initiative trials in people at high risk.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue
Poster
Wed Nov 18
7:15am–5:30pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Banner Alzheimer's Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction